News More Canadians, Americans open to psychedelic therapy, surveys show Toronto-based Field Trip launched two new polls that show more people are open to using psychedelics to treat rising pandemic-related mental health issues Jared GnamMay 20, 2021
Culture Becoming light through the darkness: My first ibogaine trip Writer Suzannah Weiss details her experience of physical and mental healing, accompanied by comic illustrations Suzannah WeissMay 14, 2021
News FDA lifts ban on study of therapists taking MDMA After two years of dispute, MAPS is celebrating the decision Natalia Buendia CalvilloMay 14, 2021
Canada Numinus to test natural psilocybin safety in Phase 1 trial Study aims to prove safety of psilocybe mushrooms so Canadian regulators can expand access to psychedelic therapy Jared GnamApril 27, 2021
Medical and Pharmaceutical Psilocybin treats depression as well as common antidepressant: study The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine Jared GnamApril 15, 2021
Canada Schedule I tea at the Coca Leaf Café Vancouver activist Dana Larsen is pushing the drug-reform conversation past cannabis by opening the doors of his entheogenic coffee shop Natalia Buendia CalvilloApril 7, 2021
Medical and Pharmaceutical LSD could be used to treat people with autism, study suggests Early evidence shows LSD promotes social behaviour in rodents, but pharmaceutical research is still a ways off Natalia Buendia CalvilloMarch 1, 2021
Medical and Pharmaceutical Nature amplifies therapeutic effects of psychedelics: study A recent review suggests natural settings and activities can complement all stages of psychedelic-assisted therapy Natalia Buendia CalvilloFebruary 23, 2021
Analysis Field Trip white paper makes strong health and business case for ketamine therapy With solid efficacy and low cost, the popular club drug could help curb the personal toll and multi-billion dollar cost of North America's battle... Natalia Buendia CalvilloFebruary 9, 2021
Canada Proposed amendment could greatly expand access to psychedelic therapy in Canada Proposed by Health Canada, the change would allow patients to access restricted substances like MDMA through the Special Access Program Natalia Buendia CalvilloJanuary 28, 2021